This report contains market size and forecasts of Non-Peptide Drugs of Angiotensin II Receptor Antagonist in Global, including the following market information:
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Peptide Drugs of Angiotensin II Receptor Antagonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Valsartan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Peptide Drugs of Angiotensin II Receptor Antagonist include Pfizer, Novartis, Merck, AstraZeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Peptide Drugs of Angiotensin II Receptor Antagonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Segment Percentages, by Type, 2021 (%)
Valsartan
Irbesartan
Candesartan Cilexetil
Eprosartan
Irbesartan
Telmisartan
losartan
Olmesartan Medoxomil
Allisartan isoproxil
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Segment Percentages, by Application, 2021 (%)
High Blood Pressure
Congestive Heart Failure
Left Ventricular Hypertrophy
Atherosclerosis
Other
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Peptide Drugs of Angiotensin II Receptor Antagonist revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Peptide Drugs of Angiotensin II Receptor Antagonist revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Merck
AstraZeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Shenzhen Salubris Pharmaceuticals 
Sun Pharmaceutical
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Amneal Pharmaceuticals
Boehringer Ingelheim